Literature DB >> 14646393

Endocrine disorders of sodium regulation. Role of adrenal steroids in genetic defects causing sodium loss or sodium retention.

Ursula Kuhnle1, Sabina Lewicka, Peter J Fuller.   

Abstract

Salt and water homoeostasis is tightly regulated by a variety of control mechanisms with the adrenal steroid hormone aldosterone playing a central role. Defects or disturbances in these systems lead to either salt loss, which is life threatening in the neonatal period, or sodium retention causing hypertension. Rapid and accurate diagnosis is required to avoid severe complications. During the last few years molecular genetic advances have been identified as the basic genetic defects for a number of clinical syndromes. This knowledge has considerably increased our understanding of the basic pathways involved in sodium and water homoeostasis and of the pathophysiology of these syndromes, particularly the hypertension. In this review we have summarized the biochemical, physiological and genetic basis for clinical syndromes presenting with salt loss and failure to thrive as well as the rare but important genetic syndromes causing sodium retention and hypertension. Early diagnosis and identification will help to prevent severe complications, but it has to be emphasized that the complicated cascade of aldosterone action is still relatively poorly understood. Further syndromes may exist which once identified will help to better understand the basic physiology of aldosterone action. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14646393     DOI: 10.1159/000075242

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  7 in total

1.  New-onset acute heart failure after intravenous glucocorticoid pulse therapy in a patient with Graves' ophthalmopathy.

Authors:  Alptekin Gursoy; Mustafa Cesur; Murat Faik Erdogan; Demet Corapcioglu; Nuri Kamel
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

Review 2.  Hyponatraemia in clinical practice.

Authors:  M Biswas; J S Davies
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

Review 3.  Adrenal Diagnostics: An Endocrinologist's Perspective focused on Hyperaldosteronism.

Authors:  Peter J Fuller
Journal:  Clin Biochem Rev       Date:  2013-11

4.  11beta-hydroxysteroid dehydrogenase type II inhibition causes cerebrovascular remodeling and increases infarct size after cerebral ischemia.

Authors:  Jessica M Osmond; Anne M Dorrance
Journal:  Endocrinology       Date:  2008-10-09       Impact factor: 4.736

5.  Aging-related impairment of urine-concentrating mechanisms correlates with dysregulation of adrenocortical angiotensin type 1 receptors in male Fischer rats.

Authors:  Hong Ji; Wei Zheng; Xie Wu; Robert C Speth; Joseph G Verbalis; Lauren M Stein; Gina L C Yosten; Willis K Samson; Kathryn Sandberg
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-12-23       Impact factor: 3.619

Review 6.  Is the mineralocorticoid receptor a potential target for stroke prevention?

Authors:  Jessica M Osmond; Christine' S Rigsby; Anne M Dorrance
Journal:  Clin Sci (Lond)       Date:  2008-01       Impact factor: 6.124

Review 7.  Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management.

Authors:  Bryan Oronsky; Scott Caroen; Arnold Oronsky; Vaughn E Dobalian; Neil Oronsky; Michelle Lybeck; Tony R Reid; Corey A Carter
Journal:  Cancer Chemother Pharmacol       Date:  2017-07-20       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.